Back to search
FDAFDA · Food and drugs·Recall number Z-1758-2020

ClearCanvas RIS/PACS

Published April 29, 2020 · Recall initiated: February 26, 2020

Summary

FDA records medical device Class II recall Z-1758-2020, published April 29, 2020 and initiated February 26, 2020. Recalling firm: Synaptive Medical Inc; Status: Terminated; Reported quantity: 903 units; Lot: ClearCanvas RIS/PACS, partt number SYN-0524 with versions 3.0 and higher. Unique Device Identifier (UDI)# (01)00670082000115 (10)1x1. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A software defect negatively affects the quality of images taken during diagnostic imaging (mammograms) which may result in misdiagnosis.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Synaptive Medical Inc
Distributor
US
Lot
ClearCanvas RIS/PACS, partt number SYN-0524 with versions 3.0 and higher. Unique Device Identifier (UDI)# (01)00670082000115 (10)1x1
Risk classification
Class II
Area (FDA)
device
Country
Canada

Related recalls

Questions about this recall

Was ClearCanvas RIS/PACS recalled?

Yes. FDA published recall Z-1758-2020 on April 29, 2020. Reported hazard: A software defect negatively affects the quality of images taken during diagnostic imaging (mammograms) which may result in misdiagnosis.

What should I do if I have this product?

Voluntary: Firm initiated · Letter